Skip to main navigation Skip to search Skip to main content

A Psychonaut's Experience of Intoxication with Multiple Classes of Drugs Including Novel Psychoactive Substance 2-fluorodeschloroketamine: Case Report and Urinary Analysis.

  • Kristina Domanski
  • , Steven W Fleming
  • , Hayden Maag
  • , Emily Bouso Raley
  • , Joshua DeBord
  • , Brooks Wright
  • , Roya Mahana
  • HCA Healthcare

Research output: Contribution to journalArticlepeer-review

Abstract

Novel psychoactive substances have emerged as drugs of abuse. 2-Fluorodeschloroketamine (2-FDCK) is a ketamine derivative that can be purchased online for as little as $12 per gram. We report the case of a patient with a history of polysubstance use presenting after insufflation of 2-FDCK, with subsequent confirmation of metabolites in the patient's urine. A 28-year-old man presented to the Emergency Department in a dissociated state. He recovered well with supportive care, and described during interview his experience of substance use including the novel psychoactive substance 2-FDCK. A urine sample was sent for analysis and 2-FDCK metabolites were isolated. This case is concerning because 2-FDCK is a relatively new agent that has not yet been reported in the United States. It is easy to obtain over the internet and has significant abuse potential.

Original languageAmerican English
JournalEmergency Medicine
StatePublished - Nov 28 2021

Keywords

  • 2-fluorodeschloroketamine
  • Novel psychoactive substances
  • ketamine

Disciplines

  • Emergency Medicine

Cite this